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Summary
This study aimed at assessing left ventricular (LV), left
atrial (LA) and right ventricular (RV) volumes in
patients before and after MitraClip™ implantation by
cardiac magnetic resonance imaging (CMR).
Background
The MitraClip™ is a novel device for percutaneous
mitral valve repair. Recent studies demonstrated a
reduction of LV volumes after MitraClip™ implantation
using echocardiography. CMR is currently the reference
method to assess cardiac volumes but has not been used
to assess LV remodeling after MitraClip™ implantation
so far.
Methods
Twelve patients with functional (n=7) or degenerative
(n=5) mitral valve regurgitation grade 3 to 4 underwent
CMR at baseline (BL) before and at 6 month follow-up
(FU) after successful MitraClip™ implantation. CMR
protocol consisted of short- and long-axis slices using a
steady-state-free-precession cine sequence for the assess-
ment of LV, LA and RV volumes.
Results
Minor device-related artifacts were observed, enabling
reliable delineation of endocardial borders in all patients
at FU. Figure 1) demonstrates typical device-related arti-
facts 6 month after implantation (A) in comparison with
a corresponding pre-implantation image (B). Mean
intra- and inter-observer biases were 0.9±2.0 and 1.6
±2.9 % for LV end-diastolic (LVEDV), 0.3±4.7 and 1.8
±6.4 % for LV end systolic (LVESV), 0.1±2.9 and 2.2±3.7
% for RVEDV, 1.7±7.8 and 3.5±8.8 % for RVESV as well
as 0.3±7.6 and 13.7±14.0 % for LA (LAV) volume
indices at FU. No significant differences in intra- or
inter-observer biases were observed between BL and FU.
LVEDV (127 (96-150) vs. 112 (86-150) ml/m
2; p=0.03)
as well as LVESV (82 (54-91) vs. 69 (48-99) ml/m
2;
p=0.03) indices significantly decreased from BL to FU.
No significant difference was found for RVEDV (94 (75-
103) vs. 99 (77-123) ml/m
2; p=0.91), RVESV (48 (42-80)
vs. 51 (40-81) ml/m
2; p=0.48) and LAV (87 (55-124) vs.
92 (48-137) ml/m
2; p=0.20) indices between BL and FU.
Conclusions
CMR enables reproducible measurements of cardiac
volumes in patients with implanted MitraClip™ devices.
Significantly decreased LV but unchanged LA and RV
volumes were found at 6 month after successful Mitra-
Clip™ implantation.
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